Historical Evolution of the Anticoagulant-Antiplatelet Therapy in Patients with Mitral Valve Disease Associated to Atrial Fibrillation or Mechanical Valve Prosthesis. Role of Omeprazole

• 作者: Ramon Bover
• 来源期刊: 心血管病(英文)
• 学科: 医学
• 关键词: Ischemic Heart Disease Anticoagulant-Antiplatelet Therapy
• 年，卷（期）: 2020,（10）
• 页码范围: 698-706
• 页数: 9页
• 分类号: R57

摘要

In this review article we analyze the historical evolution of anticoagulant and antiplatelet therapies in the treatment of atrial fibrillation plus complicated heart diseases. Its combined use, compared with anticoagulation alone, has been widely used to significantly reduce thromboembolic risk. Major bleeding risk has been usually registered during combined antithrombotic therapy, which is mainly due to gastric bleeding, but enteric coating antiplatelet tablets can effectively protect against gastric mucosal damage, and the addition of proton-pump inhibitors (omeprazole) can avoid it.